McGill researchers found lecanemab may be less effective in women, prompting calls for more personalized treatment and improved consideration of sex differences in clinical trials. Since becoming only the second Alzheimer’s-modifying drug…
New Study Questions Effectiveness of Popular Alzheimer’s Drug Leqembi in Women
